Michael Murphy
President and CEO
Gentris Corporation

Michael Murphy is the President and CEO of Gentris Corporation, a clinical pharmacogenomics testing and diagnostic products company based in Research Triangle Park, N.C.

Mr. Murphy has more than 22 years of scientific and business experience in the field of pharmacogenomics. Prior to starting Gentris in 2001, he founded Intek Labs (now part of Genaissance Pharmaceuticals), an early international pharmacogenomics company. He has also held senior management positions with PPGx and Clingenix, Inc.

Murphy is actively involved in a number of industry organizations across the country, providing recommendations and industry insight on regulatory and reimbursement issues. He is also a frequent lecturer and author on pharmacogenomic topics, and currently sits on the editorial review board of the journal Pharmacogenomics.

He is a member of AACC’s Pharmacogenomics Advisory Group, which is working to develop pharmacogenomic-focused educational programs for clinical laboratorians and other health care professionals.

Mr. Murphy s active in the Research Triangle Park entrepreneurial community, providing instruction and guidance to numerous life science companies, and serving on the planning committee for the Council for Entrepreneurial Development’s (CED) 2006 BioTech Forum.

Michael received his B.S. and M.S. degrees from San Diego State University and was trained in molecular biology at the Salk Institute.